Clinical Trial Update: Investigations on Improving Docosahexaenoic and Arachidonic Acid Content in Preterm Infant Formula [NA]

View source ↗

Summary

A completed trial update investigating optimization of docosahexaenoic and arachidonic acid content in preterm infant formula.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prematurity of Fetus

Drugs mentioned

• Arachidonic acid (arachidonic acid)
• Docosahexaenoic acid (docosahexaenoic acid)

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Prematurity of Fetus | NA | Status: COMPLETED